13F filer · CIK 902219 ↗
Wellington Management Group LLP
You are looking at Q4 2017. See the latest, Q2 2026 →
Reported value
$452.59B
+3.9% on the quarter before
Positions
2,197
234 new · 227 sold out
Top 10
14.2%
of the value
Est. gain
+$19.39B
on stocks held all quarter
Est. return
+4.8%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Wellington Management Group LLP's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 26% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Danaher Corp Del~$1.32BAdded · 0.0% → 0.3%+14,244,860 shares
- Verizon Communications Inc~$1.21BAdded · 0.9% → 1.2%+22,841,731 shares
- KLA~$725.7MAdded · 0.1% → 0.2%+6,907,016 shares
- IBM~$662.9MAdded · 0.1% → 0.2%+4,320,519 shares
- Schlumberger Ltd~$628.6MAdded · 0.3% → 0.4%+9,327,594 shares
- Union Pac Corp~$624.1MAdded · 0.5% → 0.7%+4,654,222 shares
- Edison Intl~$623.8MAdded · 0.1% → 0.2%+9,863,942 shares
- Ubs Group Ag~$550.9MAdded · 0.4% → 0.5%+29,929,208 shares
- Crown Castle Intl Corp New~$538.4MAdded · 0.0% → 0.1%+4,850,092 shares
- American Intl Group Inc~$529.8MAdded · 0.3% → 0.4%+8,892,385 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fedex Corp~$755.2MCut · 0.2% → 0.0%−3,026,346 shares
- Aetna Inc New~$659.1MCut · 0.4% → 0.2%−3,653,876 shares
- Merck & Co Inc~$648.3MCut · 1.6% → 1.2%−11,521,832 shares
- Becton Dickinson & Co~$639.2MCut · 0.2% → 0.0%−2,986,207 shares
- BlackRock~$637.4MCut · 0.7% → 0.7%−1,240,754 shares
- Anadarko Pete Corp~$636.2MCut · 0.2% → 0.1%−11,859,917 shares
- Walgreens Boots Alliance Inc~$622.0MCut · 0.7% → 0.5%−8,565,211 shares
- Bristol Myers Squibb Co~$584.0MCut · 2.2% → 1.9%−9,529,453 shares
- Wells Fargo Co New~$564.1MCut · 0.7% → 0.7%−9,298,267 shares
- Honeywell Technologies~$540.3MCut · 0.6% → 0.5%−3,522,849 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +3.0% · price +14.8% | 2.2% | $10.02B | +$1.26B | ||||||||
| Bristol Myers Squibb CoCOM · shares −6.5% · price −3.9% | 1.9% | $8.46B | −$339.7M | ||||||||
| Unitedhealth Group IncCOM · shares −2.5% · price +12.6% | 1.7% | $7.57B | +$845.0M | ||||||||
| Jpmorgan Chase & CoCOM · shares −4.1% · price +12.0% | 1.3% | $6.07B | +$648.5M | ||||||||
| Medtronic PlcSHS · shares +9.1% · price +3.8% | 1.3% | $5.79B | +$195.8M | ||||||||
| Bank Amer CorpCOM · shares +6.8% · price +16.5% | 1.2% | $5.60B | +$742.8M | ||||||||
| Verizon Communications IncCOM · shares +29% · price +7.0% | 1.2% | $5.38B | +$271.0M | ||||||||
| Merck & Co IncCOM · shares −11% · price −12.1% | 1.2% | $5.30B | −$730.3M | ||||||||
| AppleCOM · shares +7.5% · price +9.8% | 1.1% | $5.16B | +$428.1M | ||||||||
| Pnc Finl Svcs Group IncCOM · shares −3.1% · price +7.1% | 1.1% | $4.97B | +$328.0M | ||||||||
| Chevron Corp NewCOM · shares −5.5% · price +6.5% | 1.1% | $4.94B | +$303.7M | ||||||||
| Eli LillyCOM · shares −7.0% · price −1.3% | 1.1% | $4.79B | −$61.2M | ||||||||
| IntelCOM · shares −4.0% · price +21.2% | 1.00% | $4.51B | +$789.6M | ||||||||
| Chubb LimitedCOM · shares −0.7% · price +2.5% | 0.91% | $4.12B | +$101.0M | ||||||||
| Johnson & JohnsonCOM · shares −5.0% · price +7.5% | 0.90% | $4.09B | +$284.1M | ||||||||
| AlphabetCAP STK CL A · shares +3.3% · price +8.2% | 0.85% | $3.87B | +$283.2M | ||||||||
| Exxon Mobil CorpCOM · shares −4.1% · price +2.0% | 0.85% | $3.85B | +$76.3M | ||||||||
| Pepsico IncCOM · shares +3.9% · price +7.6% | 0.80% | $3.60B | +$245.3M | ||||||||
| MetaCL A · shares −6.2% · price +3.3% | 0.78% | $3.53B | +$112.0M | ||||||||
| Allergan PlcSHS · shares +9.6% · price −20.2% | 0.78% | $3.52B | −$811.6M | ||||||||
| United Parcel Service IncCL B · shares −0.9% · price −0.8% | 0.77% | $3.46B | −$27.3M | ||||||||
| CiscoCOM · shares −3.2% · price +13.9% | 0.76% | $3.45B | +$420.3M | ||||||||
| Union Pac CorpCOM · shares +23% · price +15.6% | 0.74% | $3.33B | +$365.4M | ||||||||
| Mckesson CorpCOM · shares −11% · price +1.5% | 0.72% | $3.27B | +$49.1M | ||||||||
| Citigroup IncCOM NEW · shares −11% · price +2.3% | 0.71% | $3.19B | +$71.7M | ||||||||
| Total · 2,197 positions | 100% | $452.59B | +$19.39B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 1,857 stocks held throughout, up $19.39B (+4.8%).
- Microsoft+$1.26B+15%
- Unitedhealth Group Inc+$845.0M+13%
- Intel+$789.6M+21%
- Bank Amer Corp+$742.8M+16%
- Jpmorgan Chase & Co+$648.5M+12%
- Regeneron Pharmaceuticals−$308.0M−16%
- General Electric Co−$332.1M−28%
- Bristol Myers Squibb Co−$339.7M−4%
- Merck & Co Inc−$730.3M−12%
- Allergan Plc−$811.6M−20%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 2 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $580.17B+8% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $535.46B−6% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $570.66B−0% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $571.31B+4% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $550.98B+6% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $519.87B−5% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 (amended) | $546.18B−4% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $570.97B+2% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $560.18B−1% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $564.44B+5% | SEC ↗ |
| Q4 2023 | Feb 12, 2024 (amended) | $536.37B+7% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 (amended) | $499.52B−5% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $527.49B+5% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $504.61B+1% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $498.70B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $469.49B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $496.55B−15% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $583.99B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $625.28B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $587.95B−2% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $600.78B+6% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $567.83B+5% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $543.08B+12% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $483.12B+8% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $449.13B+19% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $377.87B−21% | SEC ↗ |
| Q4 2019 | Feb 11, 2020 | $477.16B+8% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $443.46B−2% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $451.69B+2% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $441.54B+11% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $399.54B−16% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $474.88B+6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $449.23B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $441.92B−2% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $452.59B+4% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $435.63B+3% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $424.69B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $415.20B+4% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $398.65B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $399.22B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $386.87B+2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $379.99B | SEC ↗ |